IQVIA
IQV
$154.73
Share price
0.08%
Change (1 day)
-28.45%
Change (1 year)
Earnings for IQVIA (IQV)
Earnings in 2025 (TTM): $2.32 Billion USD
According to IQVIA's latest financial reports the company's current earnings are $15.49 Billion USD. In 2024 the company made an earning of $2.33 Billion USD, an increase over its 2023 earnings that were of $2.13 Billion USD. The earnings displayed on this page is the company's Pretax Income.
Earnings history for IQVIA from 2012 to 2025
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2025 (TTM)  | $2.32 B | -0.77% |
| 2024 | $2.33 B | 9.76% |
| 2023 | $2.13 B | 19.79% |
| 2022 | $1.77 B | 18.36% |
| 2021 | $1.50 B | 90.49% |
| 2020 | $0.78 B | -1.25% |
| 2019 | $0.79 B | 7.68% |
| 2018 | $0.74 B | 6.61% |
| 2017 | $0.69 B | 11.74% |
| 2016 | $0.62 B | -2.79% |
| 2015 | $0.64 B | 6.31% |
| 2014 | $0.60 B | 34.96% |
| 2013 | $0.44 B | 11.16% |
| 2012 | $0.40 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 NRC Health
NRC | $35.1 M | -98.49% | 🇺🇸 USA |
 Nymox Pharmaceutical NYMX | -$2.17 Million | -100.09% | Bahamas |